Syndax Pharmaceuticals, Inc.: net property, plant and equipment

What this measure means

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2015-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Syndax Pharmaceuticals, Inc.: total assets
• Syndax Pharmaceuticals, Inc.: total liabilities
• Syndax Pharmaceuticals, Inc.: stockholders equity
• Syndax Pharmaceuticals, Inc.: cash and cash equivalents
• Syndax Pharmaceuticals, Inc.: net income or loss
• Syndax Pharmaceuticals, Inc.: operating cash flow
• Syndax Pharmaceuticals, Inc.: capital expenditure payments
• Syndax Pharmaceuticals, Inc.: contract revenue excluding tax
• Syndax Pharmaceuticals, Inc.: financing cash flow
• Syndax Pharmaceuticals, Inc.: investing cash flow
• Syndax Pharmaceuticals, Inc.: retained earnings or deficit
• Syndax Pharmaceuticals, Inc.: basic weighted-average shares
• Syndax Pharmaceuticals, Inc.: diluted weighted-average shares
• Syndax Pharmaceuticals, Inc.: basic earnings per share
• Syndax Pharmaceuticals, Inc.: diluted earnings per share
• Syndax Pharmaceuticals, Inc.: income tax expense or benefit
• Syndax Pharmaceuticals, Inc.: share-based compensation expense
• Syndax Pharmaceuticals, Inc.: operating income or loss
• Syndax Pharmaceuticals, Inc.: current assets
• Syndax Pharmaceuticals, Inc.: interest expense
• Syndax Pharmaceuticals, Inc.: current liabilities
• Syndax Pharmaceuticals, Inc.: current accounts payable
• Syndax Pharmaceuticals, Inc.: net current accounts receivable
• Syndax Pharmaceuticals, Inc.: operating expenses
• Syndax Pharmaceuticals, Inc.: net inventory
• Syndax Pharmaceuticals, Inc.: selling, general and administrative expense
• Syndax Pharmaceuticals, Inc.: research and development expense

Inspect the source

Entity

Syndax Pharmaceuticals, Inc. / CIK 0001395937

Captured

2026-09-20T08:00:02.452Z

SEC response SHA-256

34bb57c63e172e7ddf8a6dc4a5886210e64bd006fb59459f7113dac7ea3f0a8b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001395937.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))